Genentech

About Genentech

Genentech, a member of the Roche Group, is a leading biotechnology company that has been at the forefront of innovation in the healthcare sector since its founding in 1976. The company is dedicated to developing medicines for serious and life-threatening medical conditions, focusing on areas such as oncology, immunology, and neuroscience.

With a commitment to scientific excellence, Genentech invests heavily in research and development, employing some of the brightest minds in the industry. The company’s mission is to improve the lives of patients by providing them with groundbreaking therapies that address unmet medical needs.

Genentech’s portfolio includes several pioneering treatments that have transformed patient care, particularly in cancer therapy. The company is known for its robust pipeline of investigational drugs, which are designed to tackle complex diseases through innovative mechanisms of action.

In addition to its focus on drug development, Genentech places a strong emphasis on collaboration with healthcare professionals, patients, and advocacy groups. This collaborative approach ensures that the voices of those affected by diseases are heard and considered in the development process.

Genentech also prioritises sustainability and corporate responsibility, striving to make a positive impact on the communities it serves. The company actively engages in initiatives that promote environmental stewardship and social equity.

As a leader in biotechnology, Genentech continues to push the boundaries of science and medicine, driven by a vision of a healthier future for all. The company’s dedication to innovation and patient care solidifies its position as a trusted partner in the global healthcare landscape.